Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Histone modification is key in treating chronic inflammatory skin diseases.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

The document covers various dermatological conditions and their studies.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

A group has developed therapies that show promise for treating cancer and various other conditions.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.